Logo image of SMRT

SMARTRENT INC (SMRT) Stock Fundamental Analysis

NYSE:SMRT - New York Stock Exchange, Inc. - US83193G1076 - Common Stock - Currency: USD

1.27  +0.1 (+8.55%)

After market: 1.3 +0.03 (+2.36%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to SMRT. SMRT was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. While SMRT has a great health rating, there are worries on its profitability. SMRT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SMRT had negative earnings in the past year.
In the past year SMRT has reported a negative cash flow from operations.
In the past 5 years SMRT always reported negative net income.
In the past 5 years SMRT reported 4 times negative operating cash flow.
SMRT Yearly Net Income VS EBIT VS OCF VS FCFSMRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

The Return On Assets of SMRT (-18.07%) is worse than 71.77% of its industry peers.
SMRT has a worse Return On Equity (-26.38%) than 70.97% of its industry peers.
Industry RankSector Rank
ROA -18.07%
ROE -26.38%
ROIC N/A
ROA(3y)-10.65%
ROA(5y)-8.88%
ROE(3y)-16.05%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SMRT Yearly ROA, ROE, ROICSMRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

With a Gross Margin value of 32.87%, SMRT perfoms like the industry average, outperforming 51.61% of the companies in the same industry.
In the last couple of years the Gross Margin of SMRT has grown nicely.
SMRT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 32.87%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y4.47%
SMRT Yearly Profit, Operating, Gross MarginsSMRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

More info and screens

7

2. Health

2.1 Basic Checks

SMRT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SMRT has less shares outstanding
The number of shares outstanding for SMRT has been increased compared to 5 years ago.
SMRT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SMRT Yearly Shares OutstandingSMRT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
SMRT Yearly Total Debt VS Total AssetsSMRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

SMRT has an Altman-Z score of 0.18. This is a bad value and indicates that SMRT is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.18, SMRT is not doing good in the industry: 74.19% of the companies in the same industry are doing better.
There is no outstanding debt for SMRT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.18
ROIC/WACCN/A
WACC9.63%
SMRT Yearly LT Debt VS Equity VS FCFSMRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

SMRT has a Current Ratio of 3.00. This indicates that SMRT is financially healthy and has no problem in meeting its short term obligations.
SMRT's Current ratio of 3.00 is fine compared to the rest of the industry. SMRT outperforms 62.10% of its industry peers.
A Quick Ratio of 2.57 indicates that SMRT has no problem at all paying its short term obligations.
SMRT's Quick ratio of 2.57 is fine compared to the rest of the industry. SMRT outperforms 67.74% of its industry peers.
Industry RankSector Rank
Current Ratio 3
Quick Ratio 2.57
SMRT Yearly Current Assets VS Current LiabilitesSMRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for SMRT have decreased strongly by -177.78% in the last year.
The Revenue for SMRT has decreased by -26.16% in the past year. This is quite bad
The Revenue for SMRT have been decreasing by -32.76% on average. This is quite bad
EPS 1Y (TTM)-177.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
Revenue 1Y (TTM)-26.16%
Revenue growth 3Y16.5%
Revenue growth 5Y-32.76%
Sales Q2Q%-21.04%

3.2 Future

The Earnings Per Share is expected to grow by 19.04% on average over the next years. This is quite good.
SMRT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 31.41% yearly.
EPS Next Y-147.71%
EPS Next 2Y19.04%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-11.15%
Revenue Next 2Y1.16%
Revenue Next 3Y36.2%
Revenue Next 5Y31.41%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SMRT Yearly Revenue VS EstimatesSMRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
SMRT Yearly EPS VS EstimatesSMRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -1 -2 -3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SMRT. In the last year negative earnings were reported.
Also next year SMRT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SMRT Price Earnings VS Forward Price EarningsSMRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SMRT Per share dataSMRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

SMRT's earnings are expected to grow with 19.04% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.04%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SMRT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SMARTRENT INC

NYSE:SMRT (8/8/2025, 8:04:01 PM)

After market: 1.3 +0.03 (+2.36%)

1.27

+0.1 (+8.55%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-04 2025-11-04/amc
Inst Owners62.68%
Inst Owner Change1.35%
Ins Owners8.86%
Ins Owner Change2.79%
Market Cap238.99M
Analysts45.71
Price Target1.67 (31.5%)
Short Float %2.7%
Short Ratio1.81
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-88.54%
Min EPS beat(2)-96.08%
Max EPS beat(2)-81%
EPS beat(4)0
Avg EPS beat(4)-99.31%
Min EPS beat(4)-180.11%
Max EPS beat(4)-40.06%
EPS beat(8)3
Avg EPS beat(8)-51.01%
EPS beat(12)4
Avg EPS beat(12)-37.06%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-5.1%
Min Revenue beat(2)-11.28%
Max Revenue beat(2)1.07%
Revenue beat(4)1
Avg Revenue beat(4)-7.9%
Min Revenue beat(4)-13.55%
Max Revenue beat(4)1.07%
Revenue beat(8)1
Avg Revenue beat(8)-5.22%
Revenue beat(12)3
Avg Revenue beat(12)-4.7%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-5.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-57.14%
EPS NY rev (1m)0%
EPS NY rev (3m)-134.48%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.58%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.36%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.44
P/FCF N/A
P/OCF N/A
P/B 0.95
P/tB 1.9
EV/EBITDA N/A
EPS(TTM)-0.25
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)-0.22
OCFYN/A
SpS0.88
BVpS1.33
TBVpS0.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.07%
ROE -26.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 32.87%
FCFM N/A
ROA(3y)-10.65%
ROA(5y)-8.88%
ROE(3y)-16.05%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y4.47%
F-Score5
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 145.77%
Cap/Sales 6.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3
Quick Ratio 2.57
Altman-Z 0.18
F-Score5
WACC9.63%
ROIC/WACCN/A
Cap/Depr(3y)70.42%
Cap/Depr(5y)110.3%
Cap/Sales(3y)2.2%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-177.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
EPS Next Y-147.71%
EPS Next 2Y19.04%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-26.16%
Revenue growth 3Y16.5%
Revenue growth 5Y-32.76%
Sales Q2Q%-21.04%
Revenue Next Year-11.15%
Revenue Next 2Y1.16%
Revenue Next 3Y36.2%
Revenue Next 5Y31.41%
EBIT growth 1Y-25.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year45.52%
EBIT Next 3Y60.35%
EBIT Next 5Y50.94%
FCF growth 1Y19.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y34.45%
OCF growth 3YN/A
OCF growth 5YN/A